esophageal cancer and gastroesophageal junction cancer Roboto-assisted esophagectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Intended for patients who meet all of the following criteria 1.Patients over 18 years old 2. Patients diagnosed with esophageal or gastroesophageal junction cancer 3. Patients scheduled for subtotal thoracic esophagectomy with bilateral recurrent laryngeal perineural lymph node (#106recR and #106recL) dissection 4. Those who have obtained consent to participate in this research by signing a consent form by themselves or their proxy
Exclusion criteria
Exclusion criteria: Patients who meet any of the following conditions will not be included in this study. 1. Subjects with recurrent laryngeal nerve palsy before surgery 2. Patients with heart disease (NYHA III-IV, severe arrhythmia) 3. Subjects with severe liver disorder (fulminant hepatitis, hepatic encephalopathy, Child-Pugh classification Grade C) 4. Subjects with severe renal impairment (chronic kidney disease stage 4 or 5 according to CKD guidelines) 5. Women who are pregnant or may become pregnant 6. breastfeeding woman 7. Subjects with dementia 8. Those judged inappropriate by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrent laryngeal nerve palsy (Clavien-Dindo (CD) classification 2 or higher) | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications (pneumonia, anastomotic leakage, recurrent laryngeal nerve paralysis (CD-Grade 1 or higher), pleural effusion, chylothorax, etc.), bleeding amount, operation time, number of lymph nodes dissected, delirium incidence, overall survival, recurrence-free survival rate | — |
Contacts
1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan